News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
18,588 Results
Type
Article (837)
Company Profile (3)
Press Release (17748)
Section
Business (5044)
Career Advice (3)
Deals (1073)
Drug Delivery (2)
Drug Development (2087)
Employer Resources (1)
FDA (339)
Job Trends (309)
News (8528)
Policy (719)
Tag
Academia (25)
Allergies (1)
Alliances (1559)
ALS (3)
Alzheimer's disease (7)
Antibody-drug conjugate (ADC) (1)
Approvals (344)
Artificial intelligence (13)
Autoimmune disease (1)
Automation (2)
Bankruptcy (8)
Best Places to Work (253)
Biosimilars (1)
Biotechnology (5)
Bladder cancer (6)
Brain cancer (1)
Breast cancer (3)
Cancer (78)
Cardiovascular disease (12)
Career advice (2)
CAR-T (2)
Cell therapy (13)
Clinical research (1704)
Collaboration (25)
Compensation (10)
Complete response letters (1)
COVID-19 (146)
C-suite (13)
Data (87)
Depression (1)
Diabetes (12)
Diagnostics (308)
Drug discovery (3)
Drug pricing (2)
Earnings (2112)
Editorial (1)
Employer resources (1)
Events (2883)
Executive appointments (26)
FDA (371)
Funding (17)
Gene editing (1)
Generative AI (2)
Gene therapy (5)
GLP-1 (66)
Government (69)
Guidances (1)
Healthcare (590)
Huntington's disease (1)
Immunology and inflammation (1)
Indications (2)
Infectious disease (151)
Inflammatory bowel disease (5)
Inflation Reduction Act (2)
Influenza (6)
Intellectual property (3)
IPO (457)
IRA (2)
Job creations (69)
Job search strategy (2)
Labor market (2)
Layoffs (9)
Legal (177)
Liver cancer (1)
Lung cancer (28)
Lymphoma (7)
Manufacturing (4)
MASH (2)
Medical device (533)
Medtech (533)
Mergers & acquisitions (635)
Metabolic disorders (20)
Multiple sclerosis (1)
Neurodegenerative disease (2)
Neuroscience (17)
NextGen: Class of 2025 (88)
Non-profit (20)
Now hiring (1)
Obesity (9)
Opinion (1)
Ovarian cancer (1)
Pain (2)
Pancreatic cancer (6)
Parkinson's disease (3)
Patents (3)
Patient recruitment (3)
Peanut (1)
People (1281)
Phase I (553)
Phase II (796)
Phase III (592)
Pipeline (56)
Policy (3)
Postmarket research (64)
Preclinical (234)
Press Release (1)
Radiopharmaceuticals (5)
Rare diseases (1)
Real estate (114)
Recruiting (1)
Regulatory (541)
Reports (5)
Research institute (28)
RSV (2)
Series A (4)
Series B (6)
Special edition (1)
Startups (92)
Supply chain (1)
The Weekly (1)
Vaccines (28)
Venture capitalists (2)
Weight loss (5)
Date
Last 7 days (36)
Last 30 days (101)
Last 365 days (988)
2025 (362)
2024 (1023)
2023 (1051)
2022 (2145)
2021 (1793)
2020 (1274)
2019 (930)
2018 (813)
2017 (1031)
2016 (1072)
2015 (1206)
2014 (817)
2013 (550)
2012 (702)
2011 (634)
2010 (596)
Location
Africa (9)
Alabama (2)
Arizona (4)
Asia (530)
Australia (162)
California (113)
Canada (34)
Colorado (2)
Connecticut (27)
Europe (6946)
Florida (33)
Georgia (2)
Illinois (3)
Indiana (3)
Japan (2)
Maryland (38)
Massachusetts (150)
Michigan (2)
Minnesota (3)
Missouri (1)
Nebraska (1)
Nevada (22)
New Jersey (61)
New York (11)
North Carolina (7)
Northern California (52)
Pennsylvania (21)
Rhode Island (1)
South America (12)
South Carolina (1)
Southern California (37)
Texas (22)
United States (508)
Utah (3)
Virginia (2)
Washington State (1)
18,588 Results for "galapagos nv".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
C-suite
Stoffels To Depart Galapagos, Short of Five-Year Mission To Remake the Biotech
Paul Stoffels left his perch as J&J’s chief scientific officer in 2022 to replace Galapagos’ founding CEO Onno van de Stolpe, inheriting a company that had suffered a series of clinical failures since its 1999 creation.
April 22, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Galapagos Announces Executive Leadership Updates
April 22, 2025
·
9 min read
Press Releases
Galapagos Announces Departure of Thad Huston, CFO and COO, as of August 1, 2025
April 15, 2025
·
3 min read
Cell therapy
Galapagos to Spin Out Innovative Medicines, Lay Off 40%
By mid-2025, the biotech will split into two entities: a new, as-yet-unnamed innovative medicines specialist and a cell therapy company, the latter of which will inherit the Galapagos name.
January 8, 2025
·
3 min read
·
Tristan Manalac
Business
Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.
Galapagos NV and Blood Centers of America announced that they have entered into a strategic collaboration for the decentralized manufacturing of Galapagos’ CAR-T cell therapies through BCA’s network in the U.S.
May 15, 2024
·
6 min read
Deals
Almost 5 Years into $5B Galapagos Partnership, Gilead Execs Start Over With New Spinoff
Five years ago, Gilead signed a massive deal with Galapagos. After a restructuring, the pharma is still hunting for the potential it saw at the original signing.
January 22, 2025
·
5 min read
·
Annalee Armstrong
Press Releases
Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts
April 24, 2025
·
28 min read
Business
Galapagos reports first quarter 2024 financial results
Galapagos NV announced its first quarter 2024 financial results and provided a business update and outlook for the remainder of 2024.
May 2, 2024
·
24 min read
Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024
Galapagos NV announces that all resolutions proposed at the company’s Annual and Extraordinary Shareholders’ Meetings held on 30 April 2024 were approved.
April 30, 2024
·
2 min read
Press Releases
Vivoryon Therapeutics N.V. Signs Financing Agreement for up to EUR 15 Million
April 24, 2025
·
5 min read
1 of 1,859
Next
